Maryland Health Care Product Development Corporation (MHCPDC)
Maryland Health Care Product Development Corporation (MHCPDC) has worked aggressively, since its inception in 1994, to identify promising technology investment candidates through a focused outreach program. In keeping with its first mission — to invest in early stage biomedical companies whose technology had history of federal/defense funding — the corporation has established working relationships with state, federal, and academic officials familiar with new technologies and the entrepreneurs driving their development.
The corporation's investments range in amounts from $250,000 to $1 million. MHCPDC expends significant efforts to identify and secure matching investments from commercial and state financing entities. MHCPDC's "partnership" approach to working with investment candidates is reflected in its ongoing, direct participation in the business development of its portfolio companies.
MHCPDC Board of Directors
Chairman & President
Jerry L. Parrott
President and Chief Executive Officer
Investment Advisor to the Board
Blanche Johnson, Ph.D.
Maryland Health Care Product Development Corporation
Kenneth C. Carter Ph.D.
President & Chief Executive Officer
Noble Life Sciences, Inc.
Chief Executive Officer
SDA Ventures, LLC
Edgar C. Harrell Ph.D.
Harrell Partners LLC
Capers W. McDonald
Executive in Residence and Practitioner Faculty
Johns Hopkins University/MCC
Steven L. Meltzer
Pillsbury Winthrop Shaw Pittman LLP
Edward M. Rudnic, Ph.D.
Chief Operating Officer
For additional information, contact:
Blanche Johnson, Investment Advisor
9210 Corporate Boulevard, Suite 470
Rockville, MD 20850